{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T13:54:29Z","timestamp":1761918869425},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,10,1]],"date-time":"2006-10-01T00:00:00Z","timestamp":1159660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Genetics and Cytogenetics"],"published-print":{"date-parts":[[2006,10]]},"DOI":"10.1016\/j.cancergencyto.2006.05.007","type":"journal-article","created":{"date-parts":[[2006,10,2]],"date-time":"2006-10-02T19:17:01Z","timestamp":1159816621000},"page":"115-120","source":"Crossref","is-referenced-by-count":10,"title":["Fluorescence in situ hybridization studies using BAC clones of the EVI1 locus in hematological malignancies with 3q rearrangements"],"prefix":"10.1016","volume":"170","author":[{"given":"Irene","family":"Madrigal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Carri\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e1ndida","family":"G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Rozman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordi","family":"Esteve","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benet","family":"Nomdedeu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"El\u00edas","family":"Campo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dolors","family":"Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cancergencyto.2006.05.007_bib1","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.1365-2141.1995.tb05329.x","article-title":"Abnormalities of 3q21 and 3q26 in myeloid malignancy: a United Kingdom Cancer Cytogenetic Group study","volume":"91","author":"Secker-Walker","year":"1995","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cancergencyto.2006.05.007_bib2","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1182\/blood.V88.2.682.bloodjournal882682","article-title":"Fluorescence in situ hybridization analysis of t(3;12)(q26;p13): a\u00a0recurring chromosomal abnormality involving the TEL gene (ETV6) in myelodysplastic syndromes","volume":"88","author":"Raynaud","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2006.05.007_bib3","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s00277-003-0778-y","article-title":"A novel chromosomal translocation t(3;7)(q26;q21) in myeloid leukemia resulting in overexpression of EVI1","volume":"83","author":"Storlazzi","year":"2004","journal-title":"Ann Hematol"},{"key":"10.1016\/j.cancergencyto.2006.05.007_bib4","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/s002770000158","article-title":"Low curative potential of bone marrow transplantation for highly aggressive acute myelogenous leukemia with inversion inv(3)(q21q26) or homologous translocation t(3;3)(q21;q26)","volume":"79","author":"Reiter","year":"2000","journal-title":"Ann Hematol"},{"key":"10.1016\/j.cancergencyto.2006.05.007_bib5","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/sj.onc.1200864","article-title":"The Evi-1 proto-oncogene encodes a transcriptional repressor activity associated with transformation","volume":"14","author":"Bartholomew","year":"1997","journal-title":"Oncogene"},{"key":"10.1016\/j.cancergencyto.2006.05.007_bib6","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1038\/sj.onc.1201732","article-title":"Evi-1 ZF1 DNA binding activity and a second distinct transcriptional repressor region are both required for optimal transformation of Rat1 fibroblasts","volume":"16","author":"Kilbey","year":"1998","journal-title":"Oncogene"},{"key":"10.1016\/j.cancergencyto.2006.05.007_bib7","doi-asserted-by":"crossref","first-page":"6454","DOI":"10.1073\/pnas.90.14.6454","article-title":"Loss of erythropoietin responsiveness in erythroid progenitors due to expression of the Evi-1 myeloid-transforming gene","volume":"90","author":"Kreider","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cancergencyto.2006.05.007_bib8","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S0092-8674(88)91175-0","article-title":"Retroviral activation of a novel gene encoding a zinc finger protein in IL-3-dependent myeloid leukemia cell lines","volume":"54","author":"Morishita","year":"1988","journal-title":"Cell"},{"key":"10.1016\/j.cancergencyto.2006.05.007_bib9","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.1073\/pnas.89.9.3937","article-title":"Activation of EVI1 gene expression in human acute myelogenous leukemias by translocations spanning 300\u2013400 kilobases on chromosome band 3q26","volume":"89","author":"Morishita","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cancergencyto.2006.05.007_bib10","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1182\/blood.V84.8.2681.2681","article-title":"Identification of a breakpoint cluster region 3\u2032 of the ribophorin I gene at 3q21 associated with the transcriptional activation of the EVI1 gene in acute myelogenous leukemias with inv(3)(q21q26)","volume":"84","author":"Suzukawa","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2006.05.007_bib11","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1007\/s00277-004-0932-1","article-title":"Myeloid\/natural killer cell blast crisis representing an additional translocation, t(3;7)(q26;q21) in Philadelphia-positive chronic myelogenous leukemia","volume":"83","author":"Henzan","year":"2004","journal-title":"Ann Hematol"},{"key":"10.1016\/j.cancergencyto.2006.05.007_bib12","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0145-2126(00)00031-X","article-title":"The EVI-1 gene: its role in pathogenesis of human leukemias","volume":"24","author":"Jolkowska","year":"2000","journal-title":"Leuk Res"},{"key":"10.1016\/j.cancergencyto.2006.05.007_bib13","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/j.1460-2075.1994.tb06288.x","article-title":"Generation of the AML1-EVI-1 fusion gene in the t(3;21)(q26;q22) causes blastic crisis in chronic myelocytic leukemia","volume":"13","author":"Mitani","year":"1994","journal-title":"EMBO J"},{"key":"10.1016\/j.cancergencyto.2006.05.007_bib14","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1182\/blood.V76.12.2594.2594","article-title":"t(3;21)(q26;q22): a recurring chromosomal abnormality in therapy-related myelodysplastic syndrome and acute myeloid leukemia","volume":"76","author":"Rubin","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2006.05.007_bib15","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/(SICI)1096-8652(199609)53:1<30::AID-AJH6>3.0.CO;2-6","article-title":"Expression of EVI1 and the retinoblastoma genes in acute myelogenous leukemia with t(3;13)(q26;q13-14)","volume":"53","author":"Yufu","year":"1996","journal-title":"Am J Hematol"},{"key":"10.1016\/j.cancergencyto.2006.05.007_bib16","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1046\/j.1365-2141.2001.02569.x","article-title":"MRC Adult Leukaemia Working Party. EVI1 expression in acute myeloid leukaemia","volume":"112","author":"Langabeer","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cancergencyto.2006.05.007_bib17","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1182\/blood-2002-05-1459","article-title":"High EVI1 expression predicts poor survival in acute myeloid leukemia: a study of 319 de novo AML patients","volume":"101","author":"Barjesteh van Waalwijk van Doorn-Khosrovani","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2006.05.007_bib18","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/gcc.10144","article-title":"Quantitative comparison of the expression of EVI1 and its presumptive antagonist, MDS1\/EVI1, in patients with myeloid leukemia","volume":"36","author":"Vinatzer","year":"2003","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergencyto.2006.05.007_bib19","series-title":"ISCN 2005: an international system for human cytogenetic nomenclature (2005)","year":"2005"},{"key":"10.1016\/j.cancergencyto.2006.05.007_bib20","first-page":"1427","article-title":"Deletion of sequences telomeric of the EVI1 gene in 3q26 associated with a novel pericentric inv(3)(p25q26) in a patient with acute myelogenous leukemia","volume":"88","author":"Wieser","year":"2003","journal-title":"Haematologica"},{"key":"10.1016\/j.cancergencyto.2006.05.007_bib21","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/gcc.20033","article-title":"Molecular heterogeneity in AML\/MDS patients with 3q21q26 rearrangements","volume":"40","author":"Lahortiga","year":"2004","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergencyto.2006.05.007_bib22","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00282-996-0177-7","article-title":"Cytogenetic analysis in patients with primary myelodysplastic syndromes in leukaemic transformation: a report on 94 cases","volume":"38","author":"Groupe Fran\u00e7ais de Cytog\u00e9n\u00e9tique H\u00e9matologique","year":"1996","journal-title":"Hematol Cell Ther"},{"key":"10.1016\/j.cancergencyto.2006.05.007_bib23","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/0165-4608(95)00304-5","article-title":"Translocation (2;3)(p13;q26) in two cases of myeloid malignancies: acute myeloblastic leukemia (M2) and blastic phase of chronic myeloid leukemia","volume":"87","author":"Fleischman","year":"1996","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergencyto.2006.05.007_bib24","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0165-4608(92)90169-9","article-title":"t(2;3)(p13;q26) in a case of chronic myeloid leukemia: importance of the involvement of 3q26","volume":"59","author":"Kwong","year":"1992","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergencyto.2006.05.007_bib25","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1046\/j.1365-2141.1996.17698.x","article-title":"t(2;3)(p23;q26) in a patient with AML M2","volume":"94","author":"Levaltier","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cancergencyto.2006.05.007_bib26","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1038\/sj.leu.2403346","article-title":"Translocation t(2;3)(p15-23;q26-27) in myeloid malignancies: report of 21 new cases, clinical, cytogenetic and molecular genetic features","volume":"18","author":"Stevens-Kroef","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2006.05.007_bib27","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0925-5710(98)00022-X","article-title":"A novel variant of acute myelomonocytic leukemia carrying t(3;12)(q26;p13) with characteristics of 3q21q26 syndrome","volume":"67","author":"Iwase","year":"1998","journal-title":"Int J Hematol"},{"key":"10.1016\/j.cancergencyto.2006.05.007_bib28","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1038\/sj.leu.2400765","article-title":"Unbalanced t(3;12) in a case of juvenile myelomonocytic leukemia (JMML) results in partial trisomy of 3q as defined by FISH","volume":"11","author":"Tosi","year":"1997","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2006.05.007_bib29","first-page":"31","article-title":"Cytogenetic and molecular delineation of a region of chromosome 3q commonly gained in marginal zone B-cell lymphoma","volume":"88","author":"Gazzo","year":"2003","journal-title":"Haematologica"}],"container-title":["Cancer Genetics and Cytogenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165460806003578?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165460806003578?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,18]],"date-time":"2020-04-18T11:23:35Z","timestamp":1587209015000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165460806003578"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,10]]}},"alternative-id":["S0165460806003578"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergencyto.2006.05.007","relation":{},"ISSN":["0165-4608"],"issn-type":[{"value":"0165-4608","type":"print"}],"subject":[],"published":{"date-parts":[[2006,10]]}}}